Podcasts about American Diabetes Association

Researchers from Virginia Tech have discovered that ultra-processed meats and beverages are the worst for brain health. Individuals who consumed one or more extra servings of either of these foods showed a significantly increased risk of developing cognitive impairments, including those associated with forms of dementia such as Alzheimer's Disease. A recent article from Children's Health Defense shared new research ranking which junk foods are most harmful to the brain — and it's not just about kids' waistlines or sugar highs. It's about how what we eat can shape how we think, learn, and even feel. Let's dig into what this new research is saying, and more importantly, what it means for our families. How Junk Food Impacts the Brain These studies found that foods loaded with refined sugar, unhealthy fats, and artificial ingredients don't just harm the body — they change how the brain functions. Think of it like this: the brain runs on clear signals, kind of like a radio station. When it's getting clean fuel — whole foods, real nutrients — that signal is clear. But when it's constantly fed ultra-processed foods, it's like turning up the static. The brain starts to lose focus, memory gets fuzzy, and mood and motivation can shift. Ultra-Processed Foods (UPFs) are now known to include obesity, type 2 diabetes, cardiovascular diseases, anxiety, depression, and an increase in all-cause mortality. In fact, according to a study published in Diabetes Care, a journal of the American Diabetes Association, up to 220,000 young Americans under age 20 are likely to have Type 2 diabetes by 2060 — a 673% increase from 2017 levels. One of the studies found that people who ate a lot of processed meats, fried snacks, and sugary drinks had measurable changes in the areas of the brain that control memory and emotion. Another study showed that even short-term diets high in sugar and fat can rewire how the brain's “reward center” works — making people crave those same foods even more. A study of nearly 124,000 people found that drinking just one daily serving of artificially sweetened drinks increased the risk of a liver disease known as nonalcoholic fatty liver disease or metabolic dysfunction. That means the more we eat these foods, the more our brains want them, creating a loop that's hard to break. Why Kids Are Especially Affected Recent research has shed light on a startling concern—more than 300 chemicals have been detected in babies' cord blood and placenta at birth. This discovery highlights the fact that exposure to harmful chemicals begins much earlier than we previously thought. From conception through pregnancy, toxins can pass from the mother to the fetus, raising concerns about their potential long-term effects on child development and health. Children's brains are still developing, which makes them much more sensitive to these kinds of foods. When a growing brain is constantly exposed to sugary, processed foods, it can interfere with how nerve connections form. Some of the research cited by Children's Health Defense found that kids and teens who eat a lot of junk food have more trouble with memory and learning, and can experience more mood swings or attention issues. Part of that is because junk foods crowd out the nutrients that developing brains need — like omega-3s, zinc, and iron. And part of it is chemical: those processed ingredients can actually change the way the brain's reward systems respond, which makes healthy foods less appealing over time... Click Here or Click the link below for more details! https://naturallyrecoveringautism.com/233

With November being National Diabetes Awareness Month, join us for a special episode with the CEO of the ADA, Charles Henderson! We'll have a great conversation about the growing impact of diabetes in America, how the ADA is leading the fight for awareness and access!

Emily welcomes Rachel Proper from Caterpillar Safety Services, for a special episode in recognition of National Diabetes Month. Rachel shares a deeply personal and powerful story about her 13-year-old daughter's recent diagnosis with Type 1 diabetes. She explains how her own family history with the disease allowed her to recognize the subtle but serious symptoms, leading to an early diagnosis that prevented a life-threatening situation. This episode is a crucial listen for everyone, as it details the specific signs of both high and low blood sugar. Rachel provides a firsthand account of the symptoms her daughter experienced - from unintentional weight loss and increased hunger to excessive thirst and urination. The conversation also explores the importance of fostering a "culture of care" in the workplace, where employees feel psychologically safe and supported, whether they choose to disclose a health condition or not. Rachel's story is a poignant reminder of how awareness and early detection can save lives. Main Themes: The signs and symptoms of high blood sugar (hyperglycemia), such as weight loss, excessive thirst, and frequent urination. The signs and symptoms of low blood sugar (hypoglycemia), such as shakiness, paleness, confusion, and fatigue. The role of family history and personal experience in recognizing health warning signs. The seriousness of diabetic ketoacidosis (DKA), a life-threatening complication of diabetes. The importance of creating a workplace with strong psychological safety. How a "culture of care" encourages openness and allows coworkers and leaders to provide appropriate support. Toolbox Talk Discussion Questions: In this episode, Rachel shares about how her daughter was diagnosed with Type 1 diabetes. Thanks to her awareness of the disease, Rachel and her daughter were able to seek medical attention and get her treatment before there were any serious complications. How can we relate this kind of awareness and quick thinking to safety on site? What do you think are some of the benefits of sharing important medical information with coworkers?  Does anyone have a story they would like to share about recognizing the symptoms of a disease or condition? Key Takeaways: "Type 1 diabetes is an autoimmune disease. Our body attacks insulin-producing cells in the pancreas."   "Early detection of diabetes can prevent severe complications, including death."   "A culture of care with strong psychological safety encourages openness about health conditions."   "Employees don't have to disclose they're diabetic, but sharing can help coworkers respond appropriately."   "Awareness of diabetes symptoms can help catch the disease early and save lives." Links: National Stone, Sand & Gravel Association website Take Control: Prevent Serious Injuries and Fatalities: https://www.nssga.org/industry-priorities/health-safety/take-control-prevent-serious-injuries-and-fatalities Rachel Proper: https://www.linkedin.com/in/rachelproper/ American Diabetes Association: https://diabetes.org/

This issue will review: 1.     Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis  - Diabetes Care 2.     Orforglipron, an Oral Small-Molecule GLP-1Receptor Agonist, in Early Type 2 Diabetes – NEJM 3.     Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment – NEJM 4.     Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors – Diabetes Care 5.     Impact of baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and CKD – Diabetes Care 6.     Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity -  NEJM    Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

I am thrilled to have Gary Taubes back on the show today. (He was with me before on episode 137. Gary is an investigative science and health journalist whose work has been pivotal in catalyzing the low-carb keto movement. He has written many books, including his most recent, Rethinking Diabetes, and his articles are in many of the best anthologies. He has also received many science awards. Today's discussion is particularly significant, given the recent report from the American Diabetes Association revealing that the annual cost of diabetes in the United States reached a staggering $412.9 billion in 2022, with individuals diagnosed with diabetes now representing one in every four dollars spent on healthcare.  In our discussion today, we dive into the history of diabetes, pertinent statistics, the prevailing standard of care, and the transformative influence of insulin on diabetes management and reactive hypoglycemia. Gary provides insights into his reactions to GLP ones, the integration of medical and nutrition science into the medical field, and the influence of organizations such as the American Diabetes Association, AHA, USDA, and NIH. Our discussion also extends to the effects of pharmaceuticals, the shortcomings in our approach to diabetes management and existing models, and the challenge the low-carb community faces. Stay tuned for today's eye-opening conversation, where we shed light on the complexities surrounding diabetes care, explaining how simple lifestyle changes can tremendously improve quality of life. IN THIS EPISODE YOU WILL LEARN: Rethinking Diabetes is a groundbreaking exploration of diabetes diagnosis, management, and treatment Gary discusses the evolution of evidence-based medicine Why the traditional medical approach to treating diabetes is inadequate How the guidelines of the American Diabetes Association were based on outdated assumptions  How medical treatments compare with lifestyle changes for managing diabetes Controversies surrounding how the pharmaceutical industry has influenced the way medical associations have shaped their diabetes management policies How medical guidelines and dietary advice have evolved What constitutes a healthy diet? How patients often have trouble following diet recommendations, despite their best intentions Is obesity a hormonal disorder or caused by overeating?  Connect with Cynthia Thurlow Follow on X, ⁠Instagram⁠ & ⁠LinkedIn⁠ Check out Cynthia's ⁠website⁠ Submit your questions to support@cynthiathurlow.com Connect with Gary Taubes On his ⁠website⁠ X ⁠Facebook⁠ Previous Episode Mentioned ⁠Ep. 137 – High Blood Sugar Levels And Its Long-Term Damage with Gary Taubes⁠ Book Mentioned: Rethinking Diabetes: What Science Reveals About Diet, Insulin, and Successful Treatments is available from most bookstores or on ⁠Amazon⁠.

In this episode of Diabetes Day by Day, Drs. Neil Skolnik and Sara Wettergreen talk with Aaron Sutton, LCSW, BCD, CAADC, and Casey Coffman about decision fatigue—what it means and ways to cope, especially as the holiday season approaches. Living with diabetes means making countless decisions every day—from meal choices to medication timing. Over time, this can lead to decision fatigue, impacting both your mental health and diabetes management. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Aaron Sutton, LCSW, BCD, CAADC, Director of the Sutton Institute for Psychotherapy Casey Coffman, American Diabetes Association® volunteer and a person living with type 1 diabetes Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day!

See omnystudio.com/listener for privacy information.

In this special series on Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated steatohepatitis (MASH) our host, Dr. Neil Skolnik will discuss Epidemiology, Importance, Screening and treatment of MASH. This special episode is supported by an independent educational grant from Boehringer Ingelheim. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Jay Shubrook, D.O., Professor and Diabetologist in the Department of Clinical Sciences and Community Health At Touro University California College of Osteopathic Medicine Selected references: Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care 2025;48(7):1057–1082  

This issue will review: 1.     Once-weekly Ultra-processed Foods and Diet Quality in Association With Long-term Weight Change and Progression to Type 2 Diabetes Among Individuals With a History of Gestational Diabetes Mellitus—A Prospective Study 2.     Plant-Based Dietary Patterns Associated With Reduced Risk of All-Cause Mortality in Diabetes Subgroups 3.     Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes- NEJM   4.     Risk of Phimosis Associated With SGLT2i Versus GLP-1RA: A Danish Cohort Study 5.     GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Esse tópico foi abordado na revisão 38 do Guia TdC. Para saber mais, acesse: https://www.tadeclinicagem.com.br/guia/461/diabetes-mellitus-tipo-2-atualizacao-da-american-diabetes-association-de-2025/

In this episode, representatives from the American Diabetes Association (ADA), Phil, Billy Barry, and Craig Jackson, discuss the upcoming Step Out Walk event happening on Saturday at Grand Park in Westfield, Indiana. They highlight the ADA's mission to cure, prevent, and manage diabetes, touching on the growth of diabetes cases and the importance of community awareness. The representatives also share what attendees can expect at the event, including various activities and educational opportunities. Additionally, they hint at a competitive challenge from Pittsburgh and mention future plans for the ADA, including the State of Diabetes event in November. The goal is to rally more community involvement and fundraising to support diabetes research and management.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Welcome back to Ozempic Weightloss Unlocked, the podcast dedicated to bringing you the latest news, updates, and insights on Ozempic and its impact on weight, health, and lifestyle.Today, we start with the basics: Ozempic is a medication based on semaglutide, and it is part of a class of drugs called GLP-1 receptor agonists. These drugs work by mimicking a hormone in your gut that helps regulate blood sugar and appetite. According to Purdue University, after a meal, the body naturally releases GLP-1, which helps stimulate insulin production and signals the brain to feel full. Ozempic uses a modified version of this hormone, which not only lowers blood sugar but also reduces appetite, leading to significant weight loss. Clinical studies suggest people can lose between five and twelve percent of their body weight, while also seeing improvements in blood sugar and cardiovascular health.Ozempic is recommended as the first injectable therapy for diabetes by the American Diabetes Association, but most of its headline-grabbing popularity now comes from its off-label use for weight loss. Over fifteen million adults in the United States now use medications like Ozempic, Wegovy, or similar GLP-1-based drugs. The Wall Street Journal reports that this number has been climbing steadily each year.But as more people turn to Ozempic, new challenges and concerns are emerging. The most common side effects are nausea and digestive issues, which can be so severe that up to forty percent of people stop using the drug within the first month, according to Tufts University researchers. Even for those who tolerate Ozempic, there are drawbacks. Experts at Purdue University caution that weight often returns when the drug is discontinued, meaning it is not a permanent fix. Other concerns are rising as well. Mass General Brigham recently published research in JAMA Ophthalmology that links semaglutide to a greater risk of non-arteritic anterior ischemic optic neuropathy, a condition that can cause sudden, permanent blindness. People with diabetes taking semaglutide were over four times more likely to develop this disorder than those who did not.At the same time, there is a lot of online buzz around microdosing, or taking very small amounts of GLP-1 drugs for longevity or anti-aging. The Washington Post and The Independent have both reported that leading experts see no solid scientific evidence that microdosing these drugs provides any benefit or is even safe. Companies marketing microdosing protocols are ahead of the actual science.Researchers at Tufts are now developing new medications that target even more hormone receptors, hoping to be more effective, easier to take, and come with fewer side effects. Their most recent breakthrough aims for a four-in-one drug that tackles multiple hormones tied to metabolism and appetite, with the goal of delivering even greater and longer-lasting weight loss. The hope is that future drugs could treat obesity and simultaneously reduce risks for over one hundred eighty diseases linked to excess weight, including diabetes, cancer, and heart disease.Meanwhile, there are also efforts to stimulate the body's own GLP-1 production naturally, possibly through dietary fibers or future supplements. Purdue researchers believe this could help people maintain weight loss after coming off Ozempic, without the harsh side effects of injections, though results so far show milder weight control than with the actual drug.To sum up, Ozempic has opened a new chapter in metabolic medicine, but there are still risks, unanswered questions, and an ever-changing landscape as science races forward. We will be here to keep you informed with the latest evidence and expert insights.Thank you for tuning in to Ozempic Weightloss Unlocked. If you found this episode helpful, please subscribe so you do not miss our future updates and expert interviews. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.ai

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review:   1.     Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity  - NEJM   2.     Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3)– Lancet Diabetes Endocrinology    3.     Nutritional priorities to support GLP-1 therapy for Obesity – A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society - American Journal of Clinical Nutrition 4.     Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events – Diab Care 5.     Tirzepatide as Compared with Semaglutide for the Treatment of Obesity – NEJM For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Celebrate the American Diabetes Association®'s (ADA) 85th anniversary with Drs. Neil Skolnik and Sara Wettergreen, joined by Dr. Marlon Pragnell, Charlene Wallace, and Stacey Krawczyk. Together, they'll reflect on the ADA's legacy of groundbreaking research and how it continues to shape the programs and resources available today. The conversation will also highlight practical tools—from nutrition guidance to the National Diabetes Prevention Program—to support you and your loved ones in managing or preventing diabetes. Because it all matters. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marlon Pragnell, PhD, Vice President of Research and Science at the ADA Charlene Wallace, MBA, Vice President of Diabetes Prevention at the ADA Stacey Krawczyk, MS, RD, Director of Nutrition and Wellness at the ADA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: Research Impact   Learn More About the National Diabetes Prevention Program    Eating for Diabetes Management   Diabetes Food Hub   More on the ADA's 85th Anniversary

In this special episode on Treatment of Hypercortisolism in Uncontrolled Diabetes our host, Dr. Neil Skolnik, will discuss a case based approach to uncontrolled diabetes addressing new evidence showing the surprising prevalence of Hypercortisolism in people with uncontrolled Type 2 Diabetes, and the effect of treatment.  This special episode is supported by an independent educational grant from Corcept. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John Buse, MD – The Verne S. Caviness Distinguished Professor and director of the Diabetes Center at the University of North Carolina at Chapel Hill School of Medicine, a past president of medicine & science at the American Diabetes Association (ADA), and recipient of the ADA Outstanding Achievement in Clinical Diabetes Research Award John Anderson, MD - Practices internal medicine and diabetes at the Frist Clinic in Nashville Tennessee. Servied as a Past President of the 38-member multi-specialty clinic, and has served leadership roles at Centennial Medical Center, a 670 bed HCA tertiary care referral hospital. He has served as Chair of the Department of Medicine for two separate terms. Served two separate terms on the National Board of Directors for the American Diabetes Association, and in 2013 he received the Banting Medal for service as President of Medicine and Science for the ADA.   Reference:   Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care dc242841 https://doi.org/10.2337/dc24-2841   Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment. Diabetes Care June 2025  

  From Culture to Kitchen, A Healthy Plate My interview with Lorena Drago       In this episode, we cover: Chef Robert and Lorena Drago, a registered dietitian specializing in diabetes management and multicultural nutrition, discussed the importance of accurate dietary information and cultural considerations in diabetes care. They explored common myths about diabetes in Hispanic communities and shared insights about nutritious foods from Latin American cuisine, including beans, legumes, and various fruits and vegetables. We ended the conversation with Lorena's practical advice for managing blood glucose levels while enjoying traditional foods, along with tips for healthy grocery shopping on a budget, and she offered free webinars for further education. FREE OFFER I am offering a short course for free. This is the application: https://forms.gle/QFPffvJYDwUwdamv6 ______________________________________________________________ Nutrition and Cultural Diversity Journey Lorena shared her journey into the field of nutrition, motivated by her curiosity about the relationship between food and health, particularly how food affects diabetes management and connects with different cultures. She recounted an anecdote about being confused by the Spanish word for "orange" in a commercial, which led her to discover the cultural diversity within the Hispanic community, especially within Colombia's different regions. Chef acknowledged Lorena's experience and background, setting the stage for the main discussion. Hispanic Diabetes Diet Myths Debunked Lorena discussed common myths about diabetes in the Hispanic community, emphasizing that there is no single Hispanic diet and that dietary choices can be modified to manage diabetes. She clarified that all fruits contain carbohydrates, and blood glucose response depends on the type and quantity consumed, not just the sweetness. Chef Robert agreed and expressed frustration with misleading nutrition information online, advocating for consulting certified dietitians for accurate guidance. Lorena also noted that diabetes-friendly foods vary by cuisine within the Hispanic community. Hispanic Cuisines and Bean Benefits Lorena discussed the diverse Hispanic cuisines in the United States, focusing on Mexico as the largest subgroup. She highlighted the nutritional benefits of beans and legumes, emphasizing their protein, fiber, and mineral content. Lorena advised patients to consume more beans and legumes, noting their affordability and convenience, even suggesting canned beans as a quick option. Avocado's Journey to Trendy Superfood Lorena discussed the evolution of avocado from a lesser-known food among Hispanics to its current popularity as a trendy "It" food, noting its health benefits and the shift in perceptions about dietary fats. She also highlighted other nutritious foods from Latin American cuisine, including chia seeds, pumpkin seeds, quinoa, corn, chilies, and nopal cactus pads, emphasizing their health benefits and cultural significance. Chef Robert listened and engaged with comments, expressing interest in some of the foods mentioned. Blood Glucose Management Strategies Lorena shared her step-by-step approach to helping clients manage their blood glucose levels while enjoying traditional foods. She begins by assessing how clients monitor their glucose and gathers detailed information about their diet. Lorena then recommends paired testing for 2-3 days to track blood glucose responses to meals. Finally, she provides personalized recommendations aligned with American Diabetes Association guidelines, focusing on maintaining target blood glucose levels while incorporating traditional foods. Healthy Eating Strategies and Recipes Lorena discussed strategies for healthy eating, focusing on nutrient-dense options and carbohydrate management. She suggested making a French toast alternative with fruits, nuts, and a sweetener like date paste, which has a lower glycemic response than sugar or sugar-free syrup. Lorena emphasized the importance of tracking carbohydrate intake and using tools like CGM values to adjust meals accordingly. She encouraged trying the French toast recipe three times a week and enjoying sweetbreads about twice a week. Budget-Friendly Healthy Grocery Tips Lorena shared tips for healthy grocery shopping on a budget, emphasizing the importance of buying in-season produce and using frozen foods, which can be more cost-effective and just as nutritious as fresh options. She advised using AI for meal planning, shopping during senior discounts, utilizing coupons, and incorporating soy foods like tofu for protein. Chef agreed and highlighted the benefits of frozen foods, noting that many people overlook them due to misconceptions about freshness. Diabetes Management and Professional Guidance Chef and Lorena discussed the importance of clear communication and professional guidance for individuals managing diabetes, emphasizing the need for consulting healthcare professionals and diabetes educators to separate myths from facts. Lorena expressed joy in helping people gain the knowledge and skills to manage their condition effectively, leading to improved health outcomes and reduced need for frequent visits. She shared her social media platforms in both English and Spanish as the best ways for listeners to connect with her for further support. Diabetes Management Webinar Series Lorena Drago, a diabetes management expert, offered three free webinars on managing post-meal blood glucose levels, which she will contact participants about directly. Chef interviewed Lorena about diabetes management and concluded with a rapid-fire Q&A game. Chef mentioned that the podcast episode would be available in about a week, after a brief delay due to a family celebration of their new grandchild. How can our listeners connect with you? Website:www.lorenadrago.com Instagram: https://www.instagram.com/lorenadragomsrd          TikTok URL: https://www.tiktok.com/@lorenadiabetesnutrition Facebook SPANISH URL: https://www.facebook.com/lorenadragoexpertaendiabetes/ Facebook Group URL: https://www.facebook.com/Diabetesandnutritioneducation/ Twitter(X) URL: https://twitter.com/lorenadrago  LinkedIn URL:https://www.linkedin.com/in/lorenadrago/  Instagram SPANISH URL: https://www.instagram.com/diabetesandnutritioneducation/

An episode from The Holistic Navigator. This is not to diagnosis or treat any disease/illness. Consult your physician before taking supplements or medications OR before you stop taking medications. This is for entertainment/informational purposes only! Just as a refresher, diabetes is a disease that can cause blood glucose to stay in the bloodstream for prolonged periods. Our bodies secrete a hormone called insulin from our pancreas, which helps glucose be used for energy. When diabetes comes into play, our bodies don't use insulin correctly resulting in increased blood glucose levels in the bloodstream. This can lead to cardiovascular complications, glaucoma, nerve damage and even limb amputation. It's serious stuff that affects nearly half of the American adult population according to the American Diabetes Association. On this week's episode we want to address a few of the consistent questions we've been getting about this issue. There are measures that can be taken early on to help limit your possibility of developing diabetes, mainly stemming from a diet, nutrition, and supplementation perspective. Ed talks about why American diagnoses of diabetes are increasing, the typical problem areas that can be addressed naturally, and basic supplements that can help restore optimal health. Some Topics We Discussed: What is a diagnosis of type 2 diabetes? (6:08) What can impact your A1C levels? (6:45) What are ideal blood sugar levels? (8:59) What are the negative effects of elevated insulin levels? (13:17) What would Ed do if he was diagnosed as pre-diabetic? (14:55) What is the appropriate amount of protein to consume? (24:07) This podcast is powered by ZenCast.fm

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review: 1.    Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes 2.    Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy 3.     Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study 4.    Association of Patient Cost Sharing With Adherence to GLP-1RA and Adverse Health Outcomes 5.    Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial   For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

On this episode of the Huddle, Kelly Postiglione Cook, RN, MSN, ANP-BC, CDCES, BC-ADM, and Sean Oser, MD, MPH, CDCES have a conversation about the importance of utilizing automated insulin delivery systems, like the iLet bionic pancreas, more widely in primary care. They provide insight into a study that evaluated the success of implementing use of the iLet bionic pancreas in a primary care setting, how the results illustrated that this technology can be more widely utilized in these settings, and the role diabetes care and education specialists can play in this work.This episode is sponsored by Beta Bionics. Episode References: Bionic Pancreas Research Group. Multicenter, randomized trial of a bionic pancreas in type 1 diabetes. N Engl J Med 2022;387:1161-1172 DOI: 10.1056/NEJMoa2205225 Russell SJ, Selagamsetty R, Damiano E. Real-world efficacy of the iLet bionic pancreas in adults and children during the first eighteen months of commercial availability. Presented at the American Diabetes Association 85th Scientific Sessions, June 20-23, 2025, Chicago, IL.   Oser SM, Putman MS, Russel SJ, et al. Assessing the iLet Bionic Pancreas deployed in primary care and via telehealth: a randomized clinical trial. Clin Diabetes 2025; cd240104. https://doi.org/10.2337/cd24-0104 Oser C, Parascando JA, Kostiuk M, et al. Experiences of people with type 1 diabetes using the iLet bionic pancreas in primary care: A qualitative analysis. Clin Diabetes 2024 https://doi.org/10.2337/cd24-0060.  Sulik B, Postiglione Cook K, MacLeod J. Meals no longer need to be math problems: Shifting from precise carbohydrate counting to a continuum of carbohydrate awareness as automated insulin delivery advances. Diabetes Technology and Obesity Medicine 2025;1(1):79-83. DOI: 10.1089/dtom.2025.0010.  Resources:Learn more about Beta Bionics here: https://www.betabionics.com/Explore the latest in diabetes technology on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsLearn more about a two-part course on integrating diabetes technology into primary care, put on through the collaboration of AANP and ADCES:Part 1: Integrating Diabetes Technology into Primary Care Part 1: Overview and Clinical ScenariosPart 2: Integrating Diabetes Technology into Primary Care Part 2: Interactive Case StudiesDive deeper into how diabetes technology can be incorporated into primary care on another recent episode of The Huddle featuring Kathryn Evans Kreider DNP, FNP-BC, BC-ADM, FAANP: https://thehuddle.simplecast.com/episodes/embracing-diabetes-technology-in-primary-care Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

ChatGPT recommends the Mediterranean diet as best for overall health. It groups red meat, sugar, and processed foods together as foods to avoid and recommends plant-based diets as superior. ChatGPT recommends avoiding keto and carnivore diets on a long-term basis. ChatGPT health advice comes from organizations such as the American Heart Association and the American Diabetes Association, which are heavily funded by certain industries and inherently biased. To lower cholesterol, ChatGPT claims you should lower dietary cholesterol, increase unsaturated fats, and replace animal proteins with plant proteins. Plants do not have complete protein, and if you reduce your dietary cholesterol, you could end up low in bile and vitamin D. Cholesterol is a vital component of your cell membranes, hormones, and brain.ChatGPT falsely claims that seed oils are not “that bad” when used in moderation. Balance and moderation allow you to continue eating bad food without worrying about the consequences. If you have a chronic disease, you can not simply “balance” your diet. If you have diabetes, you do not want to spike insulin with carbohydrates. ChatGPT recommends legumes and grains for people with diabetes and small, frequent meals. This advice would continue to spike insulin, and would not help reverse diabetes!When asked about diet and nutrition for people with chronic diseases, ChatGPT ignores powerful ways to drastically improve one's health, such as increasing vitamin D and fasting. It continues to recommend moderation for ultra-processed foods, claiming that it is safe and healthy for 20% of your daily calories to be ultra-processed.Dr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the author of the best-selling book The Healthy Keto Plan, and is the Director of Dr. Berg Nutritionals. He no longer practices, but focuses on health education through social media.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Takeda has taken the lead in the race for a narcolepsy treatment with back-to-back phase III wins for their drug Oveporexton. Investors are eagerly awaiting breakthroughs in using psychedelics to treat depression. Ultragenyx faced a setback as the FDA rejected their gene therapy for Sanfilippo syndrome, citing manufacturing issues. The FDA is considering speeding up reviews for companies that promise to lower drug costs. Market reaction to recent readouts from Compass Pathways and Beckley Psytech/Atai in treatment-resistant depression shows the challenges psychedelic therapies must overcome for commercial viability. Rainin Micropro offers a solution to streamline NGS preparation with their 96-channel pipettor. The industry is also focused on precision diagnostics to support precision therapeutics in the future. AstraZeneca's Baxdrostat showed promising results in lowering blood pressure in a phase III trial. The ADA revealed R&D priorities for potential blockbuster obesity treatments. Relmada has abandoned development of a depression drug after three failed attempts.The challenges faced by psychedelic therapies in the treatment of depression are discussed, as recent readouts from Compass Pathways and Beckley Psytech/Atai in treatment-resistant depression have left investors wanting more. The market reaction highlights the hurdles psychedelic therapies must overcome to prove their commercial viability. Additionally, the importance of precision diagnostics in the development of next-generation precision oncology therapies is emphasized, stating that only with the adoption of digital imaging and AI-powered analysis will these therapies reach their full potential. The FDA has several important decisions lined up, including applications in lymphoma, rare diseases, and hormone deficiency, while the American Diabetes Association's annual meeting reveals R&D priorities for weight loss medicines. Topics discussed include Capricor's FDA rejection of a DMD cell therapy, the ALS community petitioning the FDA to reconsider Brainstorm's Nurown, and updates on COVID-19 vaccines and Alzheimer's drugs. Upcoming webinars and job opportunities in the biopharma industry are also included.

Send us a textHave you ever felt a twinge of guilt or pride or suspicion when asked to donate a dollar at the checkout counter? You're not alone. In this candid conversation, we'll dive into the real emotions, questions, and choices shoppers face when confronted with checkout charity requests. We'll unpack the convenience and collective impact of small donations (did you know Americans gave over $749 million at checkout counters in just one year??) while also examining the pressures, uncertainties, and desire for more intentional giving that many of us feel.Whether you say “yes” or “no” at the register, this episode will help you reflect on your own values and boundaries around generosity. Links from today's episode:That spare change you donate at checkout is adding up to millions for charities | NPR March 10, 2024https://www.npr.org/2024/03/10/1236458377/charity-roundup-donations-stores-fundraising#:~:text=That%20spare%20change%20you%20donate,up%20to%20millions%20for%20charities&text=Norton%20for%20NPR-,So%2Dcalled%20point%2Dof%2Dsale%20donations%20have%20sharply%20increased,charity%20have%20really%20taken%20off.&text=We%27ve%20all%20been%20there,giving%20actually%20dropped%20that%20year. ICYMI another episode you might enjoy:Episode#164 Three Ways to Be More Generous This YearLove the book recos on this show? Check out the Progressive Pockets Bookshelf:https://bookshop.org/shop/progressivepockets As an affiliate of Bookshop.org, Progressive Pockets will earn a commission if you make a purchase.Connect With Genet “GG” Gimja:Website https://www.progressivepockets.comTwitter https://twitter.com/prgrssvpckts Work With Me:Email progressivepockets@gmail.com for brand partnerships, business inquiries, and speaking engagements.Easy Ways to Support the Show1. Send this episode to someone you know! Word of mouth is how podcasts grow!2. Buy me a coffee (or a soundproof panel!) https://buymeacoffee.com/progressivepockets 3. Leave a 5 star rating and review for the show!//NO AI TRAINING: Any use of this podcast episode transcript or associated show notes or blog posts to “train” generative artificial intelligence (AI) technologies to generate text is expressly prohibited. This includes, without limitation, technologies that are capable of generating works in the same style or genre as this content. The author reserves all rights to license uses of this work for generative AI training and development of machine learning language models//Support the show

Jon Easter, RPh, joined Over the Counter to discuss the main ideas of his presentation from the American Diabetes Association's 85th Scientific Sessions.

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review: 1.    Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes 2.    Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension Meta-Analysis 3.    The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact 4.    Comparative effectiveness of alternative second‐line oral glucose‐lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data 5.    Phase 3 Trial of Semaglutide in Metabolic Dysfunction– Associated Steatohepatitis   For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The Supreme Court ruled in favor of Gilead in an HIV prevention case, leaving decisions on coverage of the pre-exposure prophylaxis drug to a task force led by RFK Jr. A depression drug missed its phase II endpoint but showed positive signals in other areas. The ACIP committee is scrutinizing the safety of mRNA vaccines, while analysts are focusing on safety data presented by Novo, Lilly, and Amgen at the American Diabetes Association meeting.In other news, the FDA blocked an accelerated path for a Becker muscular dystrophy drug, Altimmune's stock dropped due to mixed mid-stage data, and Calico entered into an aging research deal with Mabwell. ACIP also voted to remove thimerosal from all flu vaccines, and former regulators expressed concerns about the integrity of the FDA approval process. These updates cover a range of developments in the pharmaceutical industry, shedding light on key advancements and challenges within the healthcare sector.

Robert F. Kennedy Jr. testified in front of the House Committee on Energy and Commerce Tuesday, where Democrats confronted the health secretary on hot button issues ranging from his recent overhaul over the CDC's Advisory Committee on Immunization Practices (ACIP) committee, Kennedy's recently published—and error-ridden—MAHA report, and his threat to ban government scientists from publishing in certain medical journals.  Meanwhile, at the FDA, the mass exodus of senior leadership continues. On Monday, Jacqueline Corrigan-Curay, acting head of the Center for Drug Evaluation and Research (CDER), announced her retirement as of July. This follows the ouster of Nicole Verdun—the wildly popular director of the FDA's Office of Therapeutic Products—and her deputy, Rachael Anatol. Their involuntary departure sent shock waves through the biopharma industry, as Verdun had been considered a stabilizing force at the rapidly reshaping agency.  Speaking of the revamped ACIP, the new panel will meet for the first time Wednesday and Thursday to discuss COVID-19 vaccine safety, maternal and pediatric RSV vaccines and more, as experts question the experience and anti-vaccine views of some of Kennedy's recently appointed members and others express concern about the potential politicization of the committee.   On the clinical front, Eli Lilly, Novo Nordisk and others presented new data from their next-generation obesity programs at the American Diabetes Association's 85th Scientific Congress. After failing to impress investors—and meet its own high expectations—with CagriSema, Novo sought to reassure investors by touting a safety profile “in line with the GLP1-RA class,” and Eli Lilly reported that bimagrumab, when used alongside Novo's Wegovy, led to additional weight loss while also preserving muscle mass.  Finally, we recap BIO2025, where Jef Akst, Lori Ellis and Heather McKenzie moderated panels on cell and gene therapy, cybersecurity and AI, and accelerating market entry for rare disease treatments. Relevant to the latter discussion, congressional Republicans dropped the Orphan Cures Act from their version of President Donald Trump's “One Big Beautiful Bill Act,” and congresspeople, including Rep. Gus Bilirakis (R-Fla.) at Tuesday's hearing asked Kennedy to commit to supporting the priority review program for rare pediatric diseases, which expired at the end of last year.  

Det kan være svært at bevare optimismen, når nogle af verdens stormagter ser ud til at stå på spring ved våbenarsenalet, men på den anden side ser de globale finansmarkeder dog ikke ud til at være gået helt i panik. Millionærklubben vejrer situationen og debatterer, om man som privat investor bør foretage sig noget. I studiet tjekker teknisk analytiker Lars Persson og Nordnets investeringsøkonom, Per Hansen, markedsåbningen, og med på en telefon fra ADA, American Diabetes Association-konferencen i Chicago, leveres sidste nyt om Novo Nordisk og Eli Lilly af Claus Johansen fra Global Health Invest. Sidst i udsendelsen får vi også et brandvarmt perspektiv på de globale oliemarkeder af Arne Lohmann Rasmussen fra Global Risk Management. Vært: Bodil Johanne GantzelSee omnystudio.com/listener for privacy information.

In this episode of the Elevate Care Podcast, David Norris, CEO of Affineon Health, discusses the transformative role of AI in healthcare, particularly in alleviating provider burnout and enhancing patient care. He shares insights from his extensive experience in healthcare technology, emphasizing the need for innovative solutions to support healthcare providers overwhelmed by administrative tasks. The conversation explores how AI can streamline processes, improve patient communication, and ensure data privacy, while also addressing the challenges of adoption among healthcare professionals. Norris highlights the importance of creating a supportive environment for providers and the potential for AI to revolutionize patient-provider relationships in the future.Chapters:00:00 AI in Healthcare: A New Era04:45 Addressing Provider Burnout with AI Solutions10:50 Operationalizing AI: Protocols and Provider Control15:56 The Future of AI in Patient Care21:58 Ensuring Data Privacy and Cybersecurity in AI25:50 Looking Ahead: The Future of AI in Healthcare About David Norris: Mr. Norris is a CEO, investor, board member, advisor, and serial entrepreneur. Utilizing his extensive experience and network, he works closely with investors and boards to accelerate the growth of high potential companies. He has extensive governance experience on a wide range of boards and board committees.As a serial entrepreneur, he has founded and built companies in a number of different industries and has extensive fund-raising experience, having raised capital from VC, private equity, strategic, angel, and debt sources.Mr. Norris has held leadership positions in a number of companies including: Co-founder and CEO, Affineon Health, Chairman and CEO, Element3 Health (acquired 2022), Co-founder, Co-Founder and CEO of MD Insider (acquired by Accolade (NASDAQ:ACCD)), Co-founder and CEO of BlueCava (acquired by IDify/Adstra), Co-Founder and CEO of OnRequest Images, Co-Founder and CEO of ObjectSpace (acquired), VP/General Manager at Casco Signal Ltd (acquired by Alstom (ALO:EN)), and Toccata Systems (acquired by Chilton).Mr. Norris has extensive international business experience, having lived and worked in Europe, Asia, and the United States. He is a regular speaker at industry conferences, has lectured at organizations such as Microsoft and the Harvard Business School, has appeared on business TV programs such as CNN, Bloomberg TV, and has been quoted in publications such as The Wall Street Journal and New York Times.Mr. Norris has won various awards, including the Ernst and Young Entrepreneur of the Year, the Inc. 500, and The Software 500. He supports a number of charities including the American Diabetes Association and the National MS Society. Mr. Norris sits on a number of boards and is a senior advisor to a number of companies. He is also a very active cyclist. Sponsors: Discover how WorkWise is redefining workforce management for healthcare. Visit workwise.amnhealthcare.com to learn more.About The Show: Elevate Care delves into the latest trends, thinking, and best practices shaping the landscape of healthcare. From total talent management to solutions and strategies to expand the reach of care, we discuss methods to enable high quality, flexible workforce and care delivery. We will discuss the latest advancements in technology, the impact of emerging models and settings, physical and virtual, and address strategies to identify and obtain an optimal workforce mix. Tune in to gain valuable insights from thought leaders focused on improving healthcare quality, workforce well-being, and patient outcomes. Learn more about the show here. Find Us On:WebsiteYouTubeSpotifyAppleInstagramLinkedInXFacebook Powered by AMN Healthcare

How can patients and family members advocate for themselves in today's health care system? What are some of the bias and health equity implications for limb amputations?In this series on healthcare and social disparities, Dr. Jill Wener, a board-certified Internal Medicine specialist, anti-racism educator, meditation expert, and tapping practitioner, interviews experts and gives her own insights into multiple fields relating to social justice and anti-racism. In this episode, Jill interviews Dr. Alyson Myers, a professor and endocrinologist. They discuss Dr. Myers' goal to lower the high rate of amputations of Black and Brown persons with diabetes by using multidisciplinary care and limb salvage techniques. They also discuss risk factors, including social determinants of health, for diabetic foot ulcers and amputee and leg amputations.Dr. Alyson Myers is a Full Professor for the Department of Medicine at Montefiore Einstein in the Bronx. She also is an honorary professor at Universidad Central del Caribe in Bayamon, Puerto Rico. In 2022, she was co-awarded a Center for Diabetes Translational Research grant from the American Diabetes Association to further examine and improve the health outcomes of persons with Diabetic Foot Ulcers (DFU). Her work in diabetic foot ulcers has led to several publications as well as production of a short documentary. Dr. Myers has served two terms on the American Board of Endocrinology, Diabetes and Metabolism. She is also a proud life, silver star member of Alpha Kappa Alpha Sorority, Incorporated.LINKSInstagram: @dr.savealimb**Our website www.consciousantiracism.comYou can learn more about Dr. Wener and her online meditation and tapping courses at www.jillwener.com, and you can learn more about her online social justice course, Conscious Anti Racism: Tools for Self-Discovery, Accountability, and Meaningful Change at https://theresttechnique.com/courses/conscious-anti-racism.If you're a healthcare worker looking for a CME-accredited course, check out Conscious Anti-Racism: Tools for Self-Discovery, Accountability, and Meaningful Change in Healthcare at www.theresttechnique.com/courses/conscious-anti-racism-healthcareJoin her Conscious Anti-Racism facebook group: www.facebook.com/groups/307196473283408Follow her on:Instagram at jillwenerMDLinkedIn at jillwenermd

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review: 1.    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes 2.    Cardioprotective Glucose-Lowering Agents and Dementia Risk A Systematic Review and Meta-Analysis 3.    A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes 4.    Screening for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Advanced Fibrosis 5.    Risk of Urogenital Infections in People With Type 2 Diabetes Initiating SGLT2i Versus GLP-1RA in Routine Clinical Care   For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

Join us for a wildly entertaining and informative interview with renowned podiatrist Dr. David Alper as he shares the most jaw-dropping foot care mishaps he's encountered throughout his distinguished 30+ year career! Dr. Alper, who recently retired from his private practice in Belmont, MA, brings a wealth of experience as Emeritus Surgical staff at Harvard's Mt. Auburn Hospital and a member of the Board of Trustees of the American Podiatric Medical Association. His leadership extends beyond clinical practice—he served as President of the American Diabetes Association's New England Leadership Board for over 20 years and chaired the Belmont Board of Health for three decades. In today's interview, Dr. Alper takes us behind the scenes with stories that will make you laugh, cringe, and maybe even think twice about your summer footwear choices! From flip-flop disasters to beach glass emergencies, and patients who arrived at his clinic with situations you won't believe until you hear them. Whether you're planning a beach vacation or simply want to protect your feet this summer, you won't want to miss Dr. Alper's expert advice wrapped in these cautionary (and sometimes hilarious) tales from the frontlines of podiatric medicine. #FootHealth #SummerSafety #PodiatryStories #DrDavidAlper #BeachSafety #FootcareExpert

Dean's Chat hosts, Drs. Jeffrey Jensen and Johanna Richey welcome Dr. David Armstrong to the podcast.  This discussion wasn't about the "Diabetic Foot" as much as it was getting to know what makes the world leader in "Diabetic Foot" click.  His background and fascination with technology, intro to podiatry (he considered law) to transforming clinical opportunities at Kern Hospital and UT- San Antonio.   Dr. Armstrong is Distinguished Professor of Surgery and Neurological Surgery with Tenure at the University of Southern California. Dr. Armstrong holds a Master of Science in Tissue Repair and Wound Healing from the University of Wales College of Medicine and a PhD from the University of Manchester College of Medicine, where he was appointed Visiting Professor of Medicine. He is founder and co-Director of the Southwestern Academic Limb Salvage Alliance (SALSA).  Dr. Armstrong has produced more than 720 peer-reviewed research papers in dozens of scholarly medical journals as well as over 120 books or book chapters. He is founding co- Editor of the American Diabetes Association's (ADA) Clinical Care of the Diabetic Foot, now in its fourth edition.  Armstrong is Director of USC's National Science Foundation (NSF) funded Center to Stream Healthcare in Place (C2SHiP) which places him at the nexus of the merger of consumer electronics, wearables, and medical devices in an effort to maximize hospital-free and activity-rich days. Dr. Armstrong was selected as one of the first six International Wound Care Ambassadors and is the recipient of numerous awards and degrees by universities and international medical organizations including the inaugural Georgetown Distinguished Award for Diabetic Limb Salvage. In 2008, he was the 25th and youngest-ever member elected to the Podiatric Medicine Hall of Fame. He was the first surgeon to be appointed University Distinguished Outreach Professor at the University of Arizona. He was also the first podiatric surgeon to be selected as President of Faculty at Keck School of Medicine of USC. Furthermore, he was the first podiatric surgeon to become a member of the Society of Vascular Surgery, and the first US podiatric surgeon named fellow of the Royal College of Surgeons, Glasgow. He is the 2010 and youngest ever recipient of both the ADA's Roger Pecoraro Award and 2023 recipient of the ISDF's Karel Bakker Award, the highest awards given in the field. Dr. Armstrong is past Chair of Scientific Sessions for the ADA's Foot Care Council, and a past member of the National Board of Directors of the American Diabetes Association. He sits on the Infectious Disease Society of America's (IDSA) Diabetic Foot Infection Advisory Committee and is the US appointed delegate to the International Working Group on the Diabetic Foot (IWGDF). Dr. Armstrong is the founder and co-chair of the International Diabetic Foot Conference (DF-Con), the largest annual international symposium on the diabetic foot in the world. He is also the Founding President of the American Limb Preservation Society (ALPS), a medical and surgical society dedicated to building interdisciplinary teams to eliminate preventable amputation in the USA and worldwide. https://limbpreservationsociety.org/ https://bakodx.com/ https://bmef.org/ www.explorepodmed.org https://podiatrist2be.com/  

Join hosts Kym McNicholas, Emmy Award-winning journalist and CEO of Global PAD Association, and Dr. John Phillips, Interventional Cardiologist, as they welcome Dr. David Alper, podiatrist, to discuss critical summer foot health issues. In this episode, Dr. Alper shares entertaining stories about the biggest foot follies that occur during summer—from beach mishaps to BBQ blunders. But the conversation takes a serious turn as he reveals the hidden summer dangers for people with diabetes and peripheral artery disease (PAD). Learn essential strategies to protect vulnerable feet and prevent wounds that could lead to amputation. Dr. Alper brings decades of expertise as Emeritus Surgical staff at Harvard's Mt. Auburn Hospital and former Board of Trustees member of the American Podiatric Medical Association. His impressive background includes serving as President of the American Diabetes Association's New England Leadership Board for over 20 years and chairing the Belmont Board of Health for three decades. Whether you're concerned about your own foot health or caring for someone with circulation issues, this episode delivers valuable information that could help save limbs and lives this summer season. #FootHealth #DiabetesCare #PADAwareness #SummerSafety #HeartOfInnovation #peripheralarterydisease #padtreatment #diabetesfootcare #diabeticfoot #padsupportgroup #legcramps #legpaintreatment

Every year, the American Diabetes Association publishes updates to their Standards of Medical Care in Diabetes. This podcast highlights key changes in the 2025 Standards of Care, including new data for diabetes prevention, liver health recommendations for people with diabetes, and use of weight management medications in the diabetes population. Listen in as we discuss these updates and how they can be incorporated into your practice as a pharmacist!Presented by:Grace Nixon, PharmD, William S. Middleton Veterans Hospital

Join Drs. Neil Skolnik and Sara Wettergreen in this episode as they discuss the importance of emotional wellbeing in overall health. They will explore the connection between mental health and diabetes, focusing on how managing a chronic condition can impact the emotional lives of people living with diabetes and their families. Special guest Dr. Kelsey Brzezinski will also join the conversation.   Please note that this episode includes discussions of sensitive topics, we encourage you to listen with care and understand that the American Diabetes Association® is not an organization that specializes in mental health and only seeks to bring awareness to factors that coincide with a diabetes diagnosis. If you are experiencing challenges seek the support of a licensed medical or mental health professional. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Kelsey Brzezinski, PhD, Pediatric Psychologist at Lurie Children's Hospital of Chicago, Assistant Professor of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine, Chicago, IL   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: If you or a loved one are experiencing a mental health crisis, please call the 988 Suicide & Crisis Lifeline. SAMHSA mental health help line, which is a no-cost, confidential, 24/7, 365-day-a-year treatment referral and information service available at 1-800-662-HELP (4357). Check out the American Diabetes Association®'s newly updated Mental Health Provider Directory to find to find therapists who specialize in supporting people living with diabetes near you.  

Get a Skratch Labs sample pack on us!Support us on Patreon!Thanks, Janji! Use code YDS for 10% off!Are CGMs the new step counter—or a $200 anxiety machine? In this episode, Zoë and Kylee discuss blood sugar basics, why fluctuations are normal, and how endurance athletes can make sense of numbers like A1C and glucose spikes without spiraling into diet culture doom.We break down:Why blood sugar goes up (and why that's not a bad thing)What CGMs actually tell you (and what they don't)How stress, sleep, and undereating mess with your blood sugarCommon myths around “spiking,” bonking, and insulinWhether high-carb fueling is risky or actually the pointWhy your oatmeal might be lying to youHow to build more satisfying meals and snacks—without tracking every gramAnd of course, the history of medical professionals tasting pee, becasue, of course.We also unpack the growing trend of CGM use in healthy athletes, the risks of over-optimization, and what your doctor might be missing when they say “pre-diabetic.”

Digital Impact and the Human Element of AI-Driven Transformation: Insights from Steve Lucas

April 28, 2025 - Monica Billger, director of state government affairs at the American Diabetes Association, discusses legislation intended to make obesity treatments, including popular weight loss drugs, more accessible by mandating insurance coverage.

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review: 1.     Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) - NEJM 2.     Diabetes and Anemia – Diabetes Care 3.     Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials – Diabetes Care 4.     Cardiovascular and Kidney Outcomes and Mortality With Long- Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials – Diabetes Care 5.     Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes - NEJM   For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they share tips to increase movement in honor of April being Move More Month. Since we're all about movement and exercise, we're excited to welcome special guests Adrienne Edge and David Rachal III from the American Diabetes Association®'s (ADA) Project Power program. They'll share how you can get involved and start moving to stay healthy, prevent, or better manage type 2 diabetes. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Adrienne Edge, Founder of ProFIT Family Wellness, Community Partner and Facilitator Trainer for the ADA's Project Power program   David Rachal III, Nationally Respected Leader in Medical Fitness, Wellness, and Entrepreneurial Empowerment, Community Partner and Facilitator Trainer for the ADA's Project Power program   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   To learn more about Project Power, be sure to check out: diabetes.org/ProjectPower.

Join us for an exclusive interview with Dr. Robert Gabbay, endocrinologist and former chief medical officer of the American Diabetes Association, on "The Heart of Innovation" hosted by Dr. John Phillips and Emmy-award-winning journalist Kym McNicholas. Dr. Gabbay will share cutting-edge developments in diabetes care that go beyond just lowering A1C—they're revolutionizing heart health, kidney function, and mobility for patients! He answers questions about: - Game-changing medications that reduce heart attack risk AND help you walk farther - The latest insulin pump technology transforming daily management - Advanced diabetes screening methods catching the disease earlier than ever - How AI digital twins can visualize the impact of lifestyle changes before you make them This is your chance to learn from a leading expert who has been at the forefront of innovations in treatment options for patients with diabetes and obesity. #DiabetesInnovation #HeartHealth #TheHeartOfInnovation #GlobalPADassociation #peripheralarterydisease #diabetescure #diabetestreatment #padsupport #legcramps #legpaintreatment

In this episode of The Healthy Project, host Corey Dion Lewis sits down with Brian Foster to explore how community health workers are transforming diabetes care—especially in underserved communities. Brian shares his personal journey with type 1 diabetes and his work with the American Diabetes Association. They discuss the connection between diabetes and heart disease, health equity, patient trust, and why community-based care is critical for improving outcomes.Topics: type 1 diabetes, diabetes education, community health workers, healthcare access, health equity, social determinants of health, American Diabetes Association, chronic disease management, public health policy, Black health equity, Healthy Project Podcast ★ Support this podcast ★

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update   discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.  This issue will review: 1.    Coronary Artery Calcium-Guided Primary Prevention Strategy 2.    Health-Related Quality of Life and Health Utility after Metabolic/Bariatric Surgery vs. Medical/Lifestyle Intervention in Individuals with Type 2 Diabetes and Obesity 3.    Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study 4.    Self-Monitored Blood Glucose and Continuous Glucose Monitoring in Youth with Type 1 Diabetes and Medicaid Insurance 5.     Gestational Diabetes to Type 2 Diabetes—Is Poor Sleep to Blame?   For more information about each of ADA's science and medical journals, please visit Diabetesjournals.org. Hosts: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Chair-Department of Family Medicine, Abington Jefferson Health

We support the American Diabetes Association. To donate to a cause that is very important to us please see belowhttps://ig.me/28P8HrSDjxEqnjO

Welcome to this special series of Diabetes Core Update, titled, “What's Next”.  In this podcast series by the American Diabetes Association where each episode explores the cutting-edge world of diabetes-related treatment and care, looking at new and future enterprises advancing diabetes and obesity care.  The series features interviews with leading industry representatives, researchers, and innovators who are shaping this care. From groundbreaking new products and treatments to the latest research advances, "What's Next?" aims to have a broad scope and offers a look at the innovations that are set to transform the landscape of diabetes and related metabolic conditions.  This special edition of Diabetes Core Update, “What's Next”, is sponsored by Ciba Health. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Innocent Clement, MD MPH MBA, CEO and Founder of Ciba Health. Discussed in this Podcast: CIBA Health

Would you believe me if I told you that we could end chronic disease in 10 weeks? Watch this fascinating interview with best-selling author Nina Teicholz, Ph.D., who has been researching the dietary guidelines for over 2 decades. SUBSCRIBE TO NINA'S SUBSTACK HERE: https://unsettledscience.substack.com...Please join me in welcoming Nina Teicholz! Nina explains that a low-carb ketogenic diet is the best way to support disease reversal. There are over 100 clinical trials supporting that type 2 diabetes can be reversed in as little as 10 weeks. Hypertension, cardiovascular risk factors, non-alcoholic fatty liver disease, and other chronic diseases can potentially also be reversed with dietary changes.The reversal rate of type 2 diabetes with the standard of care from doctors is 0.1%. In clinical trials with patients following a keto diet, the reversal rate is more than 50%! Insulin manufacturers and other drug companies primarily fund the American Heart Association and American Diabetes Association, so they are subject to direct conflicts of interest. Doctors have been taught to recommend low-fat diets, and there are countless baseless claims that keto is dangerous. Dietary guidelines significantly influence most Americans. By law, all federal food programs are required to follow these guidelines. Health professionals also use them as the gold standard in nutrition. However, many conflicts of interest are involved in these guidelines, including ties to both Big Food and Big Pharma. Giving accurate dietary guidelines to the American public is the best way to combat chronic disease.To get into a healthy state of ketosis, you should eat eggs, dairy, meat, shellfish, vegetables, and low-sugar fruits. Carbohydrates trigger hunger. Without glucose, your body can access your fat stores for energy between meals.

This episode is brought to you by  Bon Charge and Momentous. We used to think circadian rhythm only applied to sleep. But emerging science has revealed a link between our circadian rhythm and metabolism, cognition, risk for chronic diseases, and many other crucial aspects of our health. Our biology was designed to live in sync with a natural light-dark cycle, but modern-day society has disrupted this natural balance.  Today on The Dhru Purohit Show, we're revisiting one of our favorite episodes with Dr. Satchin Panda. Dr. Panda dives deep into his groundbreaking circadian biology research and shares how leveraging your circadian rhythm can dramatically improve your sleep, lower your risk of chronic disease, and improve your cognitive function. They also discuss how time-restricted eating, exercise, and light can be used to help program your circadian rhythm and why it's especially important for shift workers to take advantage of these tools.  Dr. Panda is pioneering circadian biology research. He is a professor at the Salk Institute for Biological Studies, a Pew Biomedical Scholar, founder of the UC San Diego Center for Circadian Biology, and recipient of the Julie Martin Mid-Career Award in Aging Research. Dr. Panda has spoken at conferences around the world about his work on circadian rhythms and diabetes, including Diabetes UK, the American Diabetes Association, the Danish Diabetes Association, and the professional diabetes societies of Europe and Australia. In this episode, Dhru and Dr. Panda dive into: Why late-night eating is so detrimental to our health (2:15) Organ systems that have a circadian rhythm (8:24) Common ailments that could be related to circadian rhythm disturbances (14:11) Night-shift work and cancer risk (20:19) How poor sleep perpetuates bad food choices (27:00) What happens in the body when you rely on an alarm clock (44:01) Why you need to accumulate sleep debt for better sleep (51:25) Time-restricted eating and sleep (1:00:40) How to combat fragmented sleep (1:15:35) The best time to work out (1:55:50) The link between exercise and cancer (2:07:55) Positive changes for better sleep health on a global scale (2:17:20) Strategies for night-shift workers to combat circadian rhythm disruption 02:45:10) Dr. Panda's research in firefighters (2:48:46) Tips for optimizing your circadian rhythm (3:14:20) Where to follow and support Dr. Panda's work (3:27:50) Also mentioned in this episode: The Circadian Code: Lose Weight, Supercharge Your Energy, and Transform Your Health from Morning to Midnight The Circadian Diabetes Code: Discover the Right Time to Eat, Sleep, and Exercise to Prevent and Reverse Prediabetes and Diabetes Download the MyCircadianClock app Try This: 6 Crazy Facts About Sleep Try This: How Exercise Helps Fight Cancer For more on Dr. Satchin Panda, follow him on Twitter @SatchinPanda, Instagram @satchin.panda, or his Website. This episode is brought to you by Bon Charge and Momentous. Right now, BON CHARGE is offering my community 15% off; just go to boncharge.com/DHRU and use coupon code DHRU to save 15%. Optimize your energy and mental clarity with the Momentous Three: Protein, Omega-3s, and Creatine made by and used by the best. Go to livemomentous.com and enter promo code DHRU to get 20% off any order.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Let's talk about camp! It's February but signups for most diabetes summer camps are open now and I know parents have a lot of questions. I'm talking with two camp directors, both with the American Diabetes Association, about keeping up with technology changes, misconceptions around diabetes camp, the top questions they get from parents, and lots more. My guests this week are Emily Madison and Monica Montgomery, both camp directors for the ADA. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our episode on CampViews Other episodes around camp Join us at an upcoming Moms' Night Out event! Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

Welcome! and Thank you for listening.  Did you know you could get medical advice in the self checkout line in the grocery store? It is amazing where people seek advise and from whom they seek it.  With today's lack of trust in the medical industry, I cannot blame them.  I hope to provide some truthful health information in my podcasts.  Thank you for taking a listen. What was the fork in the road for your change in health trajectory?  My family history lead me to medicine, but it was a podcast on running that inspired me to change my practice.   My first marathon was to raise money for the American Diabetes Association to "find a cure".  It was changing my practice that lead to my practice success in treating diabetes.  Running has been a positive influence on my physical and mental health.  They say when you finish a marathon or an Ironman triathlon that you are changed.  It is true, but the 100 mile ultramarathon took all of that up a notch.  I will share a few stories about people in my practice that have had their own experience and others who continue to struggle.  The only difference is mindset.   I get asked frequently about supplements.  Today I will review iron and hyaluronic acid supplements.  Take a listen.  If you would like information on how to join our practice, check out the website at https://doctordulaney.com/membership/join-us/ Email me: jami@doctordulaney.com Dietitian consultations: addie@doctordulaney.com Strength training: Nathan@doctordulaney.com Water distillers: https://mypurewater.com/?sld=jdulaney  

So what the hell is going on in the world. The US shows it has learned nothing after 100 years of effing around in the mid east, The American Diabetes Association wants your story if it matches their bias, El … Continue reading →